Study S002105

NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT00013910
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 30
Lead sponsor: National Center for Research Resources (NCRR)
Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: DRUG:NNC 90-1170
Results posted: FALSE

Registered primary outcomes

None registered.

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.